Why Choose Digital PCR for Copy Number Variation (CNV) Analysis?
Copy Number Variation (CNV) analysis is essential for understanding genetic diversity and disease mechanisms. While traditional methods like Fluorescence In Situ Hybridization (FISH), Flow Cytometry, Microarray analysis, and Next-Generation Sequencing (NGS) are widely used, they each possess inherent limitations:
- Limited Quantification: FISH and Flow Cytometry offer restricted quantifiable data compared to digital PCR (dPCR), often missing subtle micro-variations.
- Complexity & Cost: NGS involves intricate workflows and high costs, and is frequently hindered by tandem repeats—a hallmark of many CNVs.
- Sensitivity Thresholds: qPCR-based methods, while effective, rely on standard curves and typically only detect variations greater than 2-fold.
In contrast, dPCR enables true absolute quantification without the need for standard curves, offering a sensitivity high enough to detect variations as low as 10%.
High sensitivity is critical for clinical insights, particularly in HER2 (ERBB2) gene amplification. Located on chromosome 17, HER2 acts as a "cellular accelerator." Abnormal amplification leads to HER2 protein overexpression, resulting in aggressive tumor growth, higher recurrence rates, and poorer prognosis.
In somatic mutation-driven breast cancers, over 20% of cases exhibit extra HER2 copies. A major challenge in tumor biopsy is the heavy presence of normal cells within the sample, which masks the CNV signal. This is where the high sensitivity of dPCR becomes indispensable for precise assessment.
- Infinite Dilution and Partitioning: DNA samples containing the target (HER2) and reference genes are highly diluted and distributed across thousands of independent micro-units (droplets or nanowells). Ideally, each unit contains either one or zero target molecules. This isolates rare targets from background "noise" and mitigates the impact of PCR inhibitors.
- Parallel PCR Amplification: PCR amplification occurs simultaneously in all independent units. Units containing the target DNA emit a fluorescent signal (positive), while those without remain dark (negative).
- Direct Counting & Poisson Statistics: By counting positive partitions and applying Poisson distribution models, dPCR calculates the absolute concentration of both HER2 and reference genes. The final CNV value is determined by the ratio of the two, eliminating the need for external standards.
Figure 1: Schematic Diagram of Digital PCR Principles.
In this workflow (Figure 2), a duplex dPCR assay uses two fluorescent dyes to evaluate HER2 and the reference gene EIF5 (known to have two copies).
As shown in Figure 3, dPCR partitions contain either HER2 (Blue), EIF5 (Green), or both (Red). Through Poisson distribution, the software determines absolute concentrations. In this example, the sample's HER2 copy number was calculated at approximately 2.92, capturing subtle gains that traditional methods might overlook.
Figure 2: Simplified Multi-target dPCR (Duplex Assay) process. Figure 3: 2D Scatter Plot for CNV Calculation.
Figure 3: 2D Scatter Plot for CNV Calculation.
Digital PCR is a cutting-edge technology based on single-molecule amplification. JLM-Lifetech’s dPCR solutions offer:
- True Absolute Quantification: Obtain direct copies/μL without standard curves.
- Ultra-High Sensitivity: Ideal for detecting rare mutations and liquid biopsies (ctDNA) where target sequences are extremely scarce.
- High Tolerance: Partitioning minimizes the effects of PCR inhibitors, ensuring reliability in complex biological samples.
- Minimized Bias: Eliminating competition between target molecules ensures authentic and reproducible results.
Applications of JLM-Lifetech dPCR:
- Rare Sequence Detection (Liquid Biopsy)
- Copy Number Variation (CNV) Analysis
- Pathogen Detection & Viral Load Monitoring
- NGS Library Quantification
- Trace Contaminant Detection
